Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06423963 · ClinicalTrials.gov registry record · NA

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

A NA study of Pancreatic Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Recruiting
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT06423963 is a NA study of Pancreatic Cancer that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 26 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06423963, a NA study of Pancreatic Cancer, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

RECRUITING
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal).

Conditions Studied

Interventions

  • BEHAVIORAL Resistance Training
  • BEHAVIORAL Physical Activity
  • BEHAVIORAL Nutrition Counseling

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2024-02-09
Est. Completion 2026-08
Phase NA

What the Registry Record Tells You About NCT06423963

The ClinicalTrials.gov registry entry for NCT06423963 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (93% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which Resistance Training is the first listed.

NCT06423963 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06423963 about?

NCT06423963 is a clinical study titled "Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer". The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal).

What is the current status of trial NCT06423963?

This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2024-02-09. Estimated completion is 2026-08.

What conditions does trial NCT06423963 study?

This clinical trial studies the following conditions: Pancreatic Cancer.

What interventions are being tested in trial NCT06423963?

The interventions under investigation include: Resistance Training (BEHAVIORAL), Physical Activity (BEHAVIORAL), Nutrition Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT06423963?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06423963 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.